Kintor Pharmaceutical (HKG:9939) released to the market its anti-hair loss product containing KX-826 as the main ingredient, according to a Tuesday filing with the Hong Kong Stock Exchange.
The company said it will look into developing KX-826 further for androgenetic alopecia or hair loss and acne while boosting its product line and promotion toward target users, the filing said.
The company's shares climbed 8% in recent Wednesday trade.
Price (HKD): $1.07, Change: $+0.08, Percent Change: +8.08%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments